How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?

Annals of the Rheumatic Diseases

Volumn 60, Issue 3, 2001, Pages 177-184

  Taylor Robinson, D ^b   Keat, A ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ARTHRITIS; BACTERIAL INFECTION; HUMAN; HYPOGAMMAGLOBULINEMIA; LYME DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, INFECTIOUS; BACTERIAL INFECTIONS; CHROMATOGRAPHY, GAS; HUMANS; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0035089086     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.3.177     Document Type: Review

References (112)

1. Rapid diagnosis of tuberculosis in the UK
2. Reactive or infectious arthritis
3. Genital mycoplasma infections
4. Microbial DNA in the synovium - A role in aetiology or a mere bystander?
5. Lyme disease: Clinical manifestations, diagnosis and treatment
6. Lyme arthritis
7. The spirochaetal origin of Lyme disease
8. Treatment of the early manifestations of Lyme disease
9. Spirochaetal antigens and lymphoid cell surface markers in Lyme synovitis
10. The pathogenesis of Lyme disease
11. Lyme arthritis. Spirochaetes found in synovial microangiopathic lesions
12. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis
13. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
14. Antibody response in Lyme disease: Evaluation of diagnostic tests
15. Cefotaxime versus penicillin in the late stage of Lyme disease - Prospective randomised therapeutic study
16. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections
17. Mycoplasma-induced arthritis
18. Color test for the measurement of antibody to T-strain mycoplasmas
19. Identification of Ureaplasma urealyticum (T-strain mycoplasma) in a patient with polyarthritis
20. Mycoplasmal (ureaplasma) septic arthritis in hypogammaglobulinaemia
21. Isolation of Mycoplasma pneumoniae from the synovial fluid of a hypogammaglobulinaemic patient in a survey of patients with inflammatory polyarthritis
22. Arthritis caused by M. salivarium in hypogammaglobulinaemia
23. Primary late-onset hypogammaglobulinaemia associated with inflammatory polyarthritis and septic arthritis due to Mycoplasma pneumoniae
24. Ureaplasma urealyticum polyarthritis in agammaglobulinemia
25. Ureaplasma urealyticum septic arthritis in hypogammaglobulinemia
26. Septic osteomyelitis and polyarthritis with ureaplasma in hypogammaglobulinemia
27. Clinical and biological characteristics of ureaplasma urealyticum induced polyarthritis in a patient with common variable hypogammaglobulinaemia
28. Extragenital Mycoplasma hominis infections in adults: Emphasis on immunosuppression
29. Ureaplasma urealyticum destructive septic polyarthritis revealing a common variable immunodeficiency
30. Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis
31. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: Microbiological observations over twenty years
32. Molecular diagnosis of Ureaplasma urealyticum septic arthritis in a patient with hypogammaglobulinaemia
33. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: Clinical features and outcome in 18 patients
34. Arthritisit réactionnelle à Ureaplasma urealyticum
35. Ureaplasma urealyticum and arthritis
36. Molecular detection of bacterial DNA in venereal-associated arthritis
37. Molecular diagnosis of Ureaplasma urealyticum in an immunocompetent patient with destructive reactive polyarthritis
38. Isolement de Mycoplasma fermentans (Mf) et d'Ureaplasma urealyticum (Uu) á partir du liquide synovial au cours d'une arthrite réactionnelle
39. Lymphocytes from the site of disease but not blood lymphocytes indicate the cause of arthritis
40. Cell-mediated immune responses of synovial mononuclear cells in Reiter's syndrome against ureaplasmal and chlamydial antigens
41. Ureaplasma urealyticum in Reiter's syndrome
42. Mycoplasma genitalium in the joint of two patients with arthritis
43. Complement-fixing antibodies to Bedsonia in Reiter's syndrome, TRIC agent infection, and control groups
44. Frequent association of chlamydial infection with Reiter's syndrome
45. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis
46. Chlamydial isolations and serology in Reiter's syndrome
47. Urethral chlamydial infections in men with Reiter's syndrome
48. Chlamydia trachomatis and reactive arthritis: The missing link
49. Arthritis presumably caused by chlamydia in Reiter's syndrome
50. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome: Immunohistochemical identification of chlamydial antigens in patients with early disease
51. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction
52. Molecular evidence for the presence of Chlamydia in the synovium of patients with Reiter's syndrome
53. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis
54. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies
55. PCR screening of synovial tissue vs fluid from patients with Reiter's syndrome and other spondyloarthropathies for Chlamydia trachomatis
56. Case report: In situ hybridization for detection of inapparent infection with Chlamydia trachomatis in synovial tissue of a patient with Reiter's syndrome
57. Chlamydial DNA is absent from the joints of patients with sexually acquired reactive arthritis
58. A search for Chlamydia trachomatis in synovial fluids from patients with reactive arthritis using the polymerase chain reaction and antigen detection methods
59. Evidence that Chlamydia trachomatis causes seronegative arthritis in women
60. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides
61. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. II. Examination of sacroiliac and knee joint biopsies of patients with spondyloarthropathies and other arthritides
62. Synovial T lymphocyte recognition of organisms that trigger reactive arthritis
63. Cell mediated immune responses to chlamydial antigens in sexually acquired reactive arthritis
64. Synovial T lymphocyte-specific immune response to Chlamydia trachomatis in Reiter's disease
65. T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis
66. Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones
67. Antigen-presenting cells but not lymphocytes in the joint may indicate the cause of reactive arthritis
68. Immunological basis of chlamydia induced reactive arthritis
69. Chlamydial infection in the aetiology of arthritis
70. A new respiratory pathogen: Chlamydia pneumoniae strain TWAR
71. Infections caused by Chlamydia pneumoniae strain TWAR
72. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
73. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae
74. Chlamydia pneumoniae as a cause of reactive arthritis
75. Reactive arthritis ascribed to Chlamydia pneumoniae. Report of a case
76. Chlamydia pneumoniae - Reactive arthritis and persistent infection
77. Uveite et arthralges sans atteinte pulmonaire relevant une infection a Chlamydia pneumoniae
78. Chlamydia pneumoniae-infektion in einer famile
79. Chlamydia pneumoniae as a triggering infection in reactive arthritis
80. Chlamydia pneumoniae - A new causative agent of reactive arthritis and undifferentiated oligoarthritis
81. Screening of synovial tissue from reactive arthritis (ReA) patients for the presence of Chlamydia pneumoniae
82. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an anti-chlamydial immune response
83. Isolation of mycoplasmas (PPLO) from patients with rheumatoid arthritis, systemic lupus and Reiter's syndrome
84. Search for infectious agents in rheumatoid arthritis
85. Characterization of mycoplasma strains and antibody studies from patients with rheumatoid arthritis
86. Mycoplasmas in cell cultures from rheumatoid synovial membrane
87. Recovery of mycoplasma from rheumatoid synovial fluid
88. Pathogenic mycoplasma in rheumatoid arthritis?
89. Do mycoplasmas cause rheumatic disease?
90. Rheumatoid arthritis: New findings on the failure to isolate or detect mycoplasmas by multiple cultivation or serologic procedures and review of the literature
91. Mycoplasmas of the human urogenital tract and oropharynx and their possible role in disease: A review with some recent observations
92. Mycoplasmas and bacteria in synovial fluid from patients with arthritis
93. Mycoplasmas and arthritis: A systematic culture study of synovial fluids
94. Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders
95. Detection of Mycoplasma fermentans, but not M. penetrans, by PCR assays in synovial samples from patients with rheumatoid arthritis and other rheumatic disorders
96. Mycoplasmas and arthritides
97. Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1
98. Detection of Mycoplasma fermentans in human saliva with a polymerase chain reaction-based assay
99. Mycoplasma infection and rheumatoid arthritis
100. Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycosides in vitro
101. Minocycline in active rheumatoid arthritis
102. Minocycline in rheumatoid arthritis: A 48-week, double-blind, placebo-controlled trial
103. Prevalence and significance of Mycoplasma hominis and Ureaplasma urealyticum in the urines of a non-venereal disease population
104. The prevalence of Ureaplasma urealyticum and Mycoplasma hominis in the cervix and anal canal of women
105. Prevalence of Chlamydia trachomatis by PCR in the synovium of patients with early rheumatoid arthritis
106. Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis
107. An association of Chlamydia pneumoniae with juvenile chronic arthritis
108. Synovial fluid muramic acid in acute inflammatory arthritis
109. Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids
110. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides